Literature DB >> 6140089

The natural history and dose-response characteristics of enzyme-altered foci in rat liver following phenobarbital and diethylnitrosamine administration.

T Goldsworthy, H A Campbell, H C Pitot.   

Abstract

Enzyme-altered foci (EAF) were induced in the liver of female rats by 70% partial hepatectomy (PH), followed by a single intragastric administration of diethylnitrosamine (DEN) at a dose of 10 mg/kg. The stability and response of these foci to various doses of the hepatic promoting agent, phenobarbital (PB), were studied. The number of gamma-glutamyltranspeptidase-positive (GGT+) EAF resulting from PH/DEN followed by PB (0.05%) administration for 1 week, 2 weeks, 1 month, 2 months, 3 months or 4 months did not significantly change when the administration of the promoting agent was followed by a 6-month period of a diet containing no PB. These data demonstrate the stability of the foci induced by the PH/DEN/PB regimen and indicate that the increased number of foci resulting from PB promotion in the absence of overt hepatic necrosis are not reversible on removal of the promoting stimulus. Chronic administration of dose levels of PB below 0.001% in the diet failed to demonstrate an increase in the number of EAF over the number in the control animals not promoted with PB. A linear increase in the number of EAF was observed when rats were chronically fed doses of PB ranging between 0.001% and 0.05% in the diet, whereas diet concentrations of PB greater than 0.05% did not result in any further increase in the number of EAF. The number of EAF resulting from PH/DEN followed by 0.05% PB in the diet increased during the first 3-4 months of promotion. Thereafter, the number of foci did not change despite the continued administration of PB for as long as 8 months. These data suggest the presence of an apparent threshold (no effect level) for promotion by PB and demonstrate the presence of a maximal response of EAF to this promoting agent after initiation by a single dose of DEN.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6140089     DOI: 10.1093/carcin/5.1.67

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  9 in total

1.  Assessment of hepatic initiation-promotion properties of trichloroacetic acid.

Authors:  M J Parnell; J H Exon; L D Koller
Journal:  Arch Environ Contam Toxicol       Date:  1988-07       Impact factor: 2.804

Review 2.  Tumor promotion in the liver.

Authors:  R Schulte-Hermann
Journal:  Arch Toxicol       Date:  1985-08       Impact factor: 5.153

Review 3.  Overdose toxicity studies versus threshold: elements of biology must be incorporated into risk assessment.

Authors:  A G Hildebrandt
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

4.  Persistent proliferation of normal hepatocytes and promotion of preneoplastic development by N-nitrosodibenzylamine in rats.

Authors:  H Blaszyk; A Hartmann; M Danz
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

5.  Dose-response relationship for phenobarbitone promotion of liver tumours initiated by single dose dimethylnitrosamine.

Authors:  H E Driver; A E McLean
Journal:  Br J Exp Pathol       Date:  1986-02

6.  Sequential cellular changes during chemical carcinogenesis.

Authors:  P Bannasch
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

Review 7.  Multistage carcinogenesis: implications for risk estimation.

Authors:  H Yamasaki
Journal:  Cancer Metastasis Rev       Date:  1988-04       Impact factor: 9.264

8.  An approach to the determination of the relative potencies of chemical agents during the stages of initiation and promotion in multistage hepatocarcinogenesis in the rat.

Authors:  H C Pitot; H A Campbell
Journal:  Environ Health Perspect       Date:  1987-12       Impact factor: 9.031

9.  Trichloroacetic acid effects on rat liver peroxisomes and enzyme-altered foci.

Authors:  M J Parnell; L D Koller; J H Exon; J M Arnzen
Journal:  Environ Health Perspect       Date:  1986-11       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.